NTLA Intellia Therapeutics, Inc.
Healthcare$12.60+1.86%ClosedMarket Cap: $1.41B
As of 2026-05-25
Institutional Ownership Summary
Investors Holding
316
13F Shares
104,220,978
Ownership %
94.6%
New Positions
63
Increased Positions
163
Closed Positions
58
Reduced Positions
90
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
| ARK Genomic Revolution ETF | 2,917,689 | 3.68% | |
| ARK Innovation ETF | 9,355,330 | 2.10% | |
| Direxion Moonshot Innovators ETF | 15,243 | 2.01% | |
| 10,997 | 1.29% | ||
| 10,637 | 1.16% | ||
| Global X - Genomics & Biotechnology ETF | 45,069 | 1.16% | |
| Virtus Biotech Clinical Trials ETF | 30,230 | 1.07% | |
| Horizon Kinetics Medical ETF | 13,188 | 0.93% | |
| 3,753,333 | 0.63% | ||
| Direxion Daily S&P Biotech Bull 3X ETF | 187,947 | 0.50% | |
| iShares Genomics Immunology and Healthcare ETF | 60,261 | 0.49% | |
| 152,137 | 0.36% | ||
| Tema Cardiovascular and Metabolic ETF | 14,076 | 0.35% | |
| State Street SPDR S&P Kensho New Economies Composite ETF | 329,884 | 0.17% | |
| Invesco RAFI US 1500 Small-Mid ETF | 370,318 | 0.17% | |
| 399,761 | 0.15% | ||
| 1,574,262 | 0.14% | ||
| iShares Biotechnology ETF | 835,337 | 0.13% | |
| Goldman Sachs Innovate Equity ETF | 15,929 | 0.10% | |
| 12,275 | 0.10% |